Searching…
查看更多內容 4 天前 · Products Every product is the result of 1,500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription.
2025年8月27日 · Pfizer-BioNTech COVID-19 Vaccine On August 27, 2025, the Food and Drug Administration revoked the emergency use authorization (EUA) of Pfizer-BioNTech COVID-19 Vaccine.
5 天前 · The Pfizer-BioNTech study halt comes ahead of an expected May meeting of the FDA's Vaccines and Related Biological Products Advisory Committee, which would use study data to guide …
3 天前 · Pfizer and BioNTech stopped COVID-19 illness surveillance after April 3 following enrollment closure, citing inadequate recruitment to meet FDA-required post-marketing evidence thresholds. …
2023年3月16日 · 中央流行疫情指揮中心今 (16)日表示，有關國內現有之Pfizer/BioNTech COVID-19疫苗未解凍效期，已核准由原廠製造日起12個月展延至18個月，其中成人劑型未解凍效期展延至今 …
2020年11月18日 · 一家以科学为基础的、创新的、以患者为先的生物制药公司 主要功效分析表明：在首次接种后28天开始，BNT162b2对新冠肺炎的预防作用为95%；评估了170例确诊的新冠肺炎病例， …
5 天前 · London – Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too low to ...
4 天前 · Pfizer and BioNTech have stopped enrollment in a large U.S.-based trial of their updated COVID-19 vaccine in response to slow enrollment. The study was designed to recruit 25,000 to …
